Skip to content
EvidenceHelixEvidenceLib · Scientific Encyclopedia
⌘ K

Scientific library

EvidenceLib encyclopediaAll articles A–Z2,100Open textbooks2Cancer study catalog458How it is made

My workspace this browser

Saved pages0Notes & annotations0

Recently viewed

Explore by field

Cancer and Oncology107Genetics and Genomics95Neuroscience110Cardiovascular Medicine105Immunology90Pharmacology99Molecular Biology100Infectious Diseases102Rare and Inherited Diseases106Clinical Research98Anatomy and Physiology542Drugs and Chemicals546
Plans & pricingCompare EvidenceHelix workspace plans
Library›EvidenceLib›Drugs and Chemicals›Pituitary Hormones
Explore more with EvidenceHelix Workspace

Compare studies, analyze evidence and create research reports with premium tools.

Explore Researcher plans

Research reading room

Pituitary Hormones

Drugs and Chemicals · NLM MeSH · updated 2026-10-31 · version 1

Citations verified against PubMedNot yet clinician-reviewed9 referencesApproximately 3 min read

Hormones secreted by the pituitary gland including those from the anterior lobe (adenohypophysis), the posterior lobe (neurohypophysis), and the ill-defined intermediate lobe.

Table of Contents

1. Definition2. Research landscape3. Reading the evidence4. Open-access studies5. Key reviews6. References7. About this article

Definition and research guide

This page combines a MeSH definition, publication statistics and selected research abstracts. It is a starting point for reading the literature, not a medical textbook or a systematic evidence review.

Content available: 3 complete abstracts (551 words), 9 references. Full article text is not stored or reproduced here; follow the PMID, DOI or PMC links to read the original sources and their access terms.

Definition

Hormones secreted by the pituitary gland including those from the anterior lobe (adenohypophysis), the posterior lobe (neurohypophysis), and the ill-defined intermediate lobe. Structurally, they include small peptides, proteins, and glycoproteins. They are under the regulation of neural signals (neurotransmitters) or neuroendocrine signals (hypothalamic hormones) from the hypothalamus as well as feedback from their targets such as adrenal cortex hormones; androgens; estrogens.

Definition: NLM Medical Subject Headings (MeSH) scope note (Public domain (U.S. National Library of Medicine); attribution requested). View the MeSH record.

Also known as: Hormones, Pituitary.

Where it fits in the MeSH classification

Broader topics
Peptide Hormones
Narrower topics
Pituitary Hormones, Anterior; Pituitary Hormones, Posterior
See also
Hypopituitarism; Receptors, Pituitary Hormone

Related concepts

  • Pituitary Gland
  • Neurotransmitters
  • Hypothalamic Hormones
  • Adrenal Cortex Hormones
  • Androgens
  • Estrogens

Research landscape

PubMed indexes 297,648 records tagged with the MeSH heading “Pituitary Hormones” (counts retrieved 2026-10-31). 21,492 of them (7.2%) were published from 2020 onward, and the busiest period so far is through 1999 with 191,034 records.

Reviews account for 26,454 records (8.9%) and meta-analyses for 1,186. Randomized controlled trials number 9,885 (3.3%) as a share of all records on the topic.

PubMed records by publication periodthrough 1999: 191,034 records; 2000-2009: 47,546 records; 2010-2019: 37,576 records; 2020 onward: 21,492 records191,034through 199947,5462000-200937,5762010-201921,4922020 onward
Records in PubMed indexed with this heading, by publication period. Real counts from NCBI E-utilities; the final period covers only part of the current year. Volume reflects how much has been published, not how strong the evidence is.
Show the data
PeriodRecords
through 1999191,034
2000-200947,546
2010-201937,576
2020 onward21,492
Share of records by publication typeReviews: 8.9 percent; Meta-analyses: 0.4 percent; Randomized controlled trials: 3.3 percentReviews8.9% (26,454)Meta-analyses0.4% (1,186)Randomized controlled trials3.3% (9,885)
Share of all PubMed records on this heading that carry each publication type. Types overlap with other records, so the shares do not sum to 100%.
Publication-type chart data
Publication types among 297,648 PubMed records
TypeRecordsShare
Reviews26,4548.9%
Meta-analyses1,1860.4%
Randomized controlled trials9,8853.3%

Method: PubMed query "Pituitary Hormones"[MeSH Terms] with publication-type and date filters, retrieved 2026-10-31.

Reading the evidence in drugs and chemicals

Studies of a chemical or drug can answer very different questions: what it is and how it behaves in cells and animals, how the body handles it, and whether it changes outcomes in people. Laboratory and animal findings often do not carry over to patients, and observational studies of exposures are confounded by who uses a substance and why. Nothing on this page is a recommendation to use, avoid, start or stop any substance or medicine; talk to a qualified clinician or pharmacist about your own situation. Check the dose, the species, the comparison group and whether a patient-relevant outcome was measured.

Evidence from open-access studies

These open-access studies come from PubMed’s best-match results for this heading (papers whose main topic it is), ranked here by citation count, with one recent addition. Each abstract is reproduced in full under its recorded open licence so that you can read the authors’ own words. They illustrate the literature; they are not a systematic summary of it. Citation counts measure attention, not reliability or clinical benefit.

Study comparison — selected abstracts, not a systematic review
Study / authorsYearSource label / designEurope PMC citationsLicence / source
Long-acting growth hormone for treating growth hormone deficiency in children: a meta-analysis of randomized controlled trials focusing on changes in body mass index
Levaillant L, Bouhours-Nouet N, Emeriau F, Donzeau A, Rouleau S, Villanueva C, et al.
2026Meta-analysis
Design not recorded in structured metadata
6cc by
PMID 41787735 · DOI · PMC13099199
Oxytocin facilitates social behavior of female rats via selective modulation of interneurons in the medial prefrontal cortex
Schimmer S, Kania A, Lefevre A, Afordakos K, Wang KY, Lebedeva J, et al.
2026Research article
Design not recorded in structured metadata
5cc by
PMID 41720765 · DOI · PMC12923783
Stable clique membership in male mouse societies requires oxytocin-enabled social sensory states
Nelias C, Ghanayem S, Wolf D, Moor M, Nikolantonaki D, Turgut ED, et al.
2026Research article
Design not recorded in structured metadata
2cc by
PMID 42608410 · DOI · PMC13484484

Long-acting growth hormone for treating growth hormone deficiency in children: a meta-analysis of randomized controlled trials focusing on changes in body mass index [1]

Meta-analysis Levaillant L, Bouhours-Nouet N, Emeriau F, Donzeau A, Rouleau S, Villanueva C, et al. · · 2026 · cited 6 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
BackgoundThe purpose of this study is to compare the effect of long-acting growth hormone (LAGH) to daily GH on body mass index (BMI) in children with growth hormone deficiency (GHD).
Closing excerpt
ConclusionAn increase in body mass index SD score is associated with the first year of LAGH use.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (265 words)

BackgoundThe purpose of this study is to compare the effect of long-acting growth hormone (LAGH) to daily GH on body mass index (BMI) in children with growth hormone deficiency (GHD).MethodsWe searched the PubMed database from its inception to July 2025 and identified three relevant randomized controlled trials lasting over 6 months, with extension phases providing longitudinal BMI data. Longitudinal BMI data were available for lonapegsomatropin, somatrogon, and somapacitan, but not for polyethylene glycol LAGH.ResultsA total of 585 patients were included in the present analysis, of which 346 were in the LAGH group, and 239 were in the daily rhGH group, derived from seven original articles and two abstracts/ePosters. At 12 months, there was a significant difference in BMI SD scores between LAGH and daily GH groups (Mean difference [MD] 0.66 SDS [95% confidence interval [CI] 0.04-1.29]). BMI SDS significantly increased in the LAGH group (MD + 0.41 SDS [95% CI 0.04-0.77] from 0 to 12 months), whereas it did not change in the daily GH group (MD -0.35 SDS [95% CI -0.76 to +0.07] from 0 to 12 months). Between 12 and 24 months, after switching from daily GH to LAGH (daily GH/LAGH), or pursuing LAGH (LAGH/LAGH) in the extension phases of the studies, BMI SDS significantly increased in the daily GH/LAGH switching group (MD + 0.75 SDS [95% CI 0.24-1.27] from 12 to 24 months), whereas it remained steady in the LAGH/LAGH group. Omitting one study at a time from the meta-analysis did not materially affect the results.ConclusionAn increase in body mass index SD score is associated with the first year of LAGH use.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 41787735 · DOI · PMC13099199

Oxytocin facilitates social behavior of female rats via selective modulation of interneurons in the medial prefrontal cortex [2]

Research article Schimmer S, Kania A, Lefevre A, Afordakos K, Wang KY, Lebedeva J, et al. · · 2026 · cited 5 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
The hypothalamic neuropeptide oxytocin is best known for its prosocial behavioral effects.
Closing excerpt
We further demonstrate that activation of these OTR+ interneurons inhibits principal cells specifically projecting to the basolateral amygdala, thus providing a putative mechanism of selective oxytocin action in this sociability-promoting cortical network.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (126 words)

The hypothalamic neuropeptide oxytocin is best known for its prosocial behavioral effects. However, the precise anatomical and cellular targets for oxytocin in the cortex during social behavior remain elusive. Here we show that oxytocin neurons project directly to the medial prefrontal cortex where evoked axonal oxytocin release facilitates social behaviors in adult female rats. In conjunction, we report that local oxytocin receptor-expressing (OTR+) cells are predominantly interneurons, whose activation promotes social interaction. Notably, this prosocial effect persists even under physiological challenge (hunger), pointing to a dedicated prosocial circuit capable of overriding primary survival drives. We further demonstrate that activation of these OTR+ interneurons inhibits principal cells specifically projecting to the basolateral amygdala, thus providing a putative mechanism of selective oxytocin action in this sociability-promoting cortical network.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 41720765 · DOI · PMC12923783

Stable clique membership in male mouse societies requires oxytocin-enabled social sensory states [3]

Research article Nelias C, Ghanayem S, Wolf D, Moor M, Nikolantonaki D, Turgut ED, et al. · · 2026 · cited 2 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
The ability to establish stable de novo relationships in complex environments is essential for social functioning but disrupted in disorders such as autism.
Closing excerpt
Our findings identify oxytocin-dependent social sensory states as a necessary mechanism for forming stable relationships in complex social networks.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (160 words)

The ability to establish stable de novo relationships in complex environments is essential for social functioning but disrupted in disorders such as autism. Yet, the mechanisms supporting higher-order bonding in large groups remain unclear. Here, we introduce a naturalistic model of clique formation in mouse societies, using longitudinal tracking from large-scale video data. We show that small, stable cliques emerged from the specific group configurations. Consistently, also kinship did not significantly facilitate entry. These cohesive cliques resembled human mutually interacting rich-clubs, exhibiting high social rank and influence over non-members. We next examined whether oxytocin signaling in the olfactory cortex supports such higher-order bonding. Despite preserved social motivation, mice with conditional oxytocin receptor deletion in this sensory cortex failed to join rich-clubs, approached peers less consistently, and received unstable reciprocal connections. This network-level disorganization demonstrates how social dynamics can magnify individual deficits. Our findings identify oxytocin-dependent social sensory states as a necessary mechanism for forming stable relationships in complex social networks.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 42608410 · DOI · PMC13484484

Key reviews and meta-analyses

The most cited review-type papers among PubMed’s best-match results for this heading, listed with bibliographic details only. Follow the links for the full text and access terms.

  • Research article Sniffing around oxytocin: review and meta-analyses of trials in healthy and clinical groups with implications for pharmacotherapy [4]
    Bakermans-Kranenburg MJ, van I Jzendoorn MH · Transl Psychiatry · 2013 · cited 305 times (Europe PMC)
  • Research article A sniff of trust: meta-analysis of the effects of intranasal oxytocin administration on face recognition, trust to in-group, and trust to out-group [5]
    Van IJzendoorn MH, Bakermans-Kranenburg MJ · Psychoneuroendocrinology · 2012 · cited 243 times (Europe PMC)
  • Research article The correlation between central and peripheral oxytocin concentrations: A systematic review and meta-analysis [6]
    Valstad M, Alvares GA, Egknud M, Matziorinis AM, Andreassen OA, Westlye LT, et al. · Neurosci Biobehav Rev · 2017 · cited 212 times (Europe PMC)
  • Research article ACTH Stimulation Tests for the Diagnosis of Adrenal Insufficiency: Systematic Review and Meta-Analysis [7]
    Ospina NS, Al Nofal A, Bancos I, Javed A, Benkhadra K, Kapoor E, et al. · J Clin Endocrinol Metab · 2016 · cited 173 times (Europe PMC)
  • Research article Thyrotropin and thyroid cancer diagnosis: a systematic review and dose-response meta-analysis [8]
    McLeod DS, Watters KF, Carpenter AD, Ladenson PW, Cooper DS, Ding EL · J Clin Endocrinol Metab · 2012 · cited 154 times (Europe PMC)
  • Research article Neurophysiological effects of acute oxytocin administration: systematic review and meta-analysis of placebo-controlled imaging studies [9]
    Wigton R, Radua J, Allen P, Averbeck B, Meyer-Lindenberg A, McGuire P, et al. · J Psychiatry Neurosci · 2015 · cited 148 times (Europe PMC)

References

  1. Levaillant L, Bouhours-Nouet N, Emeriau F, Donzeau A, Rouleau S, Villanueva C, et al.. Long-acting growth hormone for treating growth hormone deficiency in children: a meta-analysis of randomized controlled trials focusing on changes in body mass index. . 2026. PMID 41787735 · DOI · PMC13099199
  2. Schimmer S, Kania A, Lefevre A, Afordakos K, Wang KY, Lebedeva J, et al.. Oxytocin facilitates social behavior of female rats via selective modulation of interneurons in the medial prefrontal cortex. . 2026. PMID 41720765 · DOI · PMC12923783
  3. Nelias C, Ghanayem S, Wolf D, Moor M, Nikolantonaki D, Turgut ED, et al.. Stable clique membership in male mouse societies requires oxytocin-enabled social sensory states. . 2026. PMID 42608410 · DOI · PMC13484484
  4. Bakermans-Kranenburg MJ, van I Jzendoorn MH. Sniffing around oxytocin: review and meta-analyses of trials in healthy and clinical groups with implications for pharmacotherapy. Transl Psychiatry. 2013. PMID 23695233 · DOI · PMC3669921
  5. Van IJzendoorn MH, Bakermans-Kranenburg MJ. A sniff of trust: meta-analysis of the effects of intranasal oxytocin administration on face recognition, trust to in-group, and trust to out-group. Psychoneuroendocrinology. 2012. PMID 21802859 · DOI
  6. Valstad M, Alvares GA, Egknud M, Matziorinis AM, Andreassen OA, Westlye LT, et al.. The correlation between central and peripheral oxytocin concentrations: A systematic review and meta-analysis. Neurosci Biobehav Rev. 2017. PMID 28442403 · DOI
  7. Ospina NS, Al Nofal A, Bancos I, Javed A, Benkhadra K, Kapoor E, et al.. ACTH Stimulation Tests for the Diagnosis of Adrenal Insufficiency: Systematic Review and Meta-Analysis. J Clin Endocrinol Metab. 2016. PMID 26649617 · DOI
  8. McLeod DS, Watters KF, Carpenter AD, Ladenson PW, Cooper DS, Ding EL. Thyrotropin and thyroid cancer diagnosis: a systematic review and dose-response meta-analysis. J Clin Endocrinol Metab. 2012. PMID 22622023 · DOI
  9. Wigton R, Radua J, Allen P, Averbeck B, Meyer-Lindenberg A, McGuire P, et al.. Neurophysiological effects of acute oxytocin administration: systematic review and meta-analysis of placebo-controlled imaging studies. J Psychiatry Neurosci. 2015. PMID 25520163 · DOI · PMC4275335

About this article

Sources
NLM Medical Subject Headings (definition, synonyms); NCBI PubMed (counts, identifiers); Europe PMC (open-access abstracts and citation counts).
Verification
Every reference was resolved against PubMed on 2026-10-31; title, year and DOI matched.
Review state
automated source verified; no human expert review has been recorded yet.
Version
1, last updated 2026-10-31.

See how EvidenceLib is built. Spotted an error? Email support@evidencehelix.com.

Evidence strength

EvidenceHelix's computed view of the study designs behind this topic: how common meta-analyses, randomized trials and reviews are, how recent the literature is, and a plain-language reading. It describes the design mix of the literature. It is not a quality appraisal of any study, and it is not medical advice.

Included with the Researcher plan

Reading every article stays free. This computed view is part of the paid plans.

See plans Sign in

Your notes

Notes and highlights stay in this browser only; they are not sent to EvidenceHelix.

Related research topics

  • Growth HormoneDrugs and Chemicals
  • Corticotropin-Releasing HormoneDrugs and Chemicals
  • ProlactinDrugs and Chemicals
  • Pro-OpiomelanocortinDrugs and Chemicals
  • Adrenocorticotropic HormoneDrugs and Chemicals
  • Follicle Stimulating HormoneDrugs and Chemicals

All 546 articles in Drugs and Chemicals →

At a glance

297,648
PubMed records on this heading
7%
published since 2020
26,454
review articles
9,885
randomized trials
9
verified references below

Counts come from PubMed on 2026-10-31; they show how much has been written, not how strong the evidence is.

Related topics See all →

  • Growth HormoneDrugs and Chemicals
  • Corticotropin-Releasing HormoneDrugs and Chemicals
  • ProlactinDrugs and Chemicals
  • Pro-OpiomelanocortinDrugs and Chemicals
  • Adrenocorticotropic HormoneDrugs and Chemicals

My notes & annotations (0)

Nothing yet. Select text and press Highlight, or write a note in the Notes tab. Stored in this browser only.

Sources

  • NLM MeSH record ↗
  • PubMed search used ↗

EvidenceLib is a research-education resource, not medical advice. It does not diagnose, prescribe or recommend starting, stopping or changing any treatment. Talk to a qualified clinician about your own situation. Methods, sources and licences · Legal · Support